K68.2
Retroperitoneal fibrosis
Clinical Classification Guidelines
Code Also
- , if applicable, associated obstruction of ureter (N13.5)
Medical Intelligence & Overview
Retroperitoneal fibrosis is a rare disorder characterized by the development of excess fibrous tissue in the retroperitoneal space, the area behind the abdominal organs. This abnormal tissue growth can compress nearby structures such as the kidneys, ureters, and blood vessels, leading to a variety of health issues. Although the exact cause of retroperitoneal fibrosis is often unknown, it may be associated with autoimmune responses, medications, or certain diseases. Due to its subtle early symptoms, diagnosis can be challenging, but timely management is essential to prevent serious complications.
Causes & Symptoms
Clinical Causes: Unknown (idiopathic), which accounts for the majority of cases Autoimmune reactions that cause the body to attack its own tissues Use of certain medications, such as ergot derivatives or beta-blockers Association with other diseases like connective tissue disorders Exposure to radiation therapy or asbestos Infections or inflammatory conditions affecting the retroperitoneal space
Key Symptoms: Back pain or dull ache in the abdomen Discomfort or pressure symptoms in the lower back or abdomen Unexplained weight loss Swelling or mass sensation in the abdomen Signs of kidney obstruction, like decreased urine output or swelling in the legs Potential urinary symptoms such as difficulty urinating or blood in the urine
Diagnostic & Treatment
Diagnosis Path: Diagnosing retroperitoneal fibrosis involves a combination of clinical evaluation and imaging studies. Healthcare providers may utilize the following:
Treatment Protocols: Management of retroperitoneal fibrosis focuses on reducing inflammation, relieving symptoms, and preventing further tissue growth. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is K68.2 a billable ICD-10 code?
Yes, K68.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K68.2?
Clinical documentation must specify the nature of Retroperitoneal fibrosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference